Christoph Schlegel
Partner,
Christoph
Christoph Schlegel is an expert in Bain's Healthcare & Life Sciences, Telecommunications and Technology practices.
He has nearly 15 years of global consulting experience, having advised clients across Bain's Frankfurt, Zurich, Munich, Dubai, Chicago and Stockholm offices.
Christoph advises clients in a variety of industries, with a focus in pharmaceuticals, biotech, medtech and telecommunications. He holds deep expertise in strategy development, in particular strategy in uncertainty, digitalization, consumer strategy and marketing as well as organization.
Christoph studied in St. Gallen and London and holds an MA in finance and capital market theory.
Bain Partners Christoph Schlegel and Hans Joachim Heider discuss the future of autonomous driving.
Recent Insights
- “Life Sciences: White-Hot Competition to Win the Right Deals,” Global Healthcare Private Equity and M&A Report, 2023年4月10日, レポート
- “Biopharma: Healthcare Private Equity Scores a Record Year in Deal Value,” Global Healthcare Private Equity and M&A Report, 2023年4月10日, レポート
- “Life Sciences Tools: Carve-outs, Mature Assets, and Innovative Growth Draw Interest,” Global Healthcare Private Equity and M&A Report, 2023年4月10日, レポート
- “Healthcare Private Equity in Europe: Funds Take On More Risk in a Hot Market,” レポート, 2022年3月15日
- “Biopharma: Traditional Pharma Services Lead the Way ,” レポート, 2022年3月15日